- Current report filing (8-K)
November 06 2008 - 4:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
November 6, 2008
GENOPTIX, INC.
(Exact name of
registrant as specified in its charter)
Delaware
|
|
001-33753
|
|
33-0840570
|
(State or other
jurisdiction
of incorporation)
|
|
(Commission File
Number)
|
|
(IRS. Employer
Identification No.)
|
2110
Rutherford Road
Carlsbad,
CA 92008
(Address of principal
executive offices, including zip code)
Registrants
telephone number, including area code:
(760) 268-6200
(Former name or
former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02.
Results of Operations and
Financial Condition.
On November 6,
2008, Genoptix, Inc., a Delaware corporation, issued a press release
announcing its financial results as of and for the three and nine months ended September 30,
2008. A copy of the press release and accompanying information is attached as Exhibit 99.1
to this current report.
The
information in this Item 2.02 and Exhibit 99.1, attached hereto, shall not
be deemed filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference into any registration
statement or other document filed with the Securities and Exchange Commission,
whether filed before or after the date hereof, and regardless of any general
incorporation language in any such filing.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits
99.1
Press Release of Genoptix, Inc. dated
November 6, 2008.
2
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
GENOPTIX, INC.
|
|
|
|
|
Date:
|
November 6, 2008
|
|
/s/ Christian V. Kuhlen, M.D., Esq.
|
|
Christian V. Kuhlen, M.D., Esq.
|
|
Vice President, General Counsel
|
|
|
|
|
3
EXHIBIT INDEX
Exhibit
|
|
|
Number
|
|
Description
|
99.1
|
|
Press Release of Genoptix, Inc. dated November 6, 2008.
|
4
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Historical Stock Chart
From Jul 2023 to Jul 2024